FG
VIR icon

Foster Group’s Vir Biotechnology VIR Stock Holding History

Foster Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
10,248
+175
+2% +$1.67K ﹤0.01% 313
2026
Q1 		$90.3K Buy
+10,073
New +$80.3K ﹤0.01% 280

Other funds holding VIR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Foster Group's VIR Position: Q2 2026 in Review

Foster Group increased its Vir Biotechnology (VIR) stake by 1.7% in Q2 2026, buying an estimated $1.67K and bringing the position to 10,248 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

Foster Group first reported a position in VIR in Q1 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Foster Group held 10,248 shares of Vir Biotechnology worth $104K as of Q2 2026.
  • Foster Group bought 175 Vir Biotechnology shares in Q2 2026, an estimated $1.67K.
  • Vir Biotechnology made up ﹤0.01% of Foster Group's portfolio in Q2 2026, its #313 holding.
  • Foster Group first reported a position in Vir Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.